In the United States, hyperlipidemia-related CVD mortality increased from 1999 to 2019, with elderly, Black, rural men being most affected. Hyperlipidemia-related cardiovascular disease (CVD) ...

Panelists discuss how: LDL-C control remains a national crisis, with many patients not on therapy or failing to reach target ...

Persons with mixed hyperlipidemia are at risk for atherosclerotic cardiovascular disease due to an elevated non–high-density lipoprotein (HDL) cholesterol level, which is driven by remnant cholesterol ...

Preexisting hyperlipidemia in pregnancy is associated with heightened risks of obstetric complications and early cardiovascular events in the first five-years postpartum, according to a new study ...

Research led by Baylor College of Medicine has shown that a new therapy significantly reduces triglyceride levels in individuals with mixed hyperlipidemia – elevations of triglycerides and cholesterol ...

Angiopoietin-like 3 (ANGPTL3) inhibits lipoprotein and endothelial lipases and hepatic uptake of triglyceride-rich lipoprotein remnants. ANGPTL3 loss-of-function carriers have lower levels of ...

Researchers have uncovered a simple magnesium-based score that could help identify which high-cholesterol patients are most likely to face deadly heart problems, years before symptoms appear. Study: ...